FR2604902B1 - Compositions pharmaceutiques a liberation prolongee - Google Patents
Compositions pharmaceutiques a liberation prolongeeInfo
- Publication number
- FR2604902B1 FR2604902B1 FR878713759A FR8713759A FR2604902B1 FR 2604902 B1 FR2604902 B1 FR 2604902B1 FR 878713759 A FR878713759 A FR 878713759A FR 8713759 A FR8713759 A FR 8713759A FR 2604902 B1 FR2604902 B1 FR 2604902B1
- Authority
- FR
- France
- Prior art keywords
- pharmaceutical compositions
- sustained release
- release pharmaceutical
- sustained
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868624213A GB8624213D0 (en) | 1986-10-09 | 1986-10-09 | Sustained release pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2604902A1 FR2604902A1 (fr) | 1988-04-15 |
| FR2604902B1 true FR2604902B1 (fr) | 1991-04-26 |
Family
ID=10605478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR878713759A Expired - Lifetime FR2604902B1 (fr) | 1986-10-09 | 1987-10-02 | Compositions pharmaceutiques a liberation prolongee |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPS63101334A (fr) |
| KR (1) | KR880004801A (fr) |
| AU (1) | AU7942087A (fr) |
| BE (1) | BE1000732A5 (fr) |
| CA (1) | CA1332809C (fr) |
| CH (1) | CH675831A5 (fr) |
| DE (1) | DE3733540A1 (fr) |
| DK (1) | DK527487A (fr) |
| ES (1) | ES2014518A6 (fr) |
| FI (1) | FI874414A (fr) |
| FR (1) | FR2604902B1 (fr) |
| GB (2) | GB8624213D0 (fr) |
| GR (1) | GR871550B (fr) |
| HU (1) | HU201875B (fr) |
| IL (1) | IL84104A0 (fr) |
| IT (1) | IT1221493B (fr) |
| LU (1) | LU87009A1 (fr) |
| NL (1) | NL8702294A (fr) |
| NO (1) | NO874200L (fr) |
| NZ (1) | NZ222083A (fr) |
| PH (1) | PH24227A (fr) |
| PT (1) | PT85880B (fr) |
| SE (1) | SE8703889L (fr) |
| ZA (1) | ZA877617B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5948437A (en) * | 1996-05-23 | 1999-09-07 | Zeneca Limited | Pharmaceutical compositions using thiazepine |
| US5895663A (en) * | 1997-07-31 | 1999-04-20 | L. Perrigo Company | Pseudoephedrine hydrochloride extended-release tablets |
| IL145661A0 (en) * | 1999-03-31 | 2002-06-30 | Janssen Pharmaceutica Nv | Pregelatinized starch in a controlled release formulation |
| US6242003B1 (en) | 2000-04-13 | 2001-06-05 | Novartis Ag | Organic compounds |
| US20060127474A1 (en) | 2001-04-11 | 2006-06-15 | Oskar Kalb | Pharmaceutical compositions comprising fluvastatin |
| SE0102887D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| SE0102886D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| SE0102888D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| TWI338583B (en) | 2004-05-20 | 2011-03-11 | Otsuka Pharma Co Ltd | Solid pharmaceutical formulation |
| DK1803447T3 (da) * | 2004-09-09 | 2009-10-12 | Psicofarma S A De C V | Farmaceutisk sammensætning til vedvarende frisætning af hydralazin og anvendelse heraf som en understötning for cancerbehandling |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE795766A (fr) * | 1972-02-22 | 1973-08-22 | Lilly Co Eli | Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules |
| US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4520009A (en) * | 1983-11-28 | 1985-05-28 | Verex Laboratories, Inc. | Sustained released aspirin formulation |
| DE3346571A1 (de) * | 1983-12-23 | 1985-07-04 | Bayer Ag, 5090 Leverkusen | Oral retardierte acetylsalicylsaeureformulierungen |
| KR850700212A (ko) * | 1984-03-21 | 1985-12-26 | 죠지 드모트 | 서방성 약제학적 캼셀제 |
-
1986
- 1986-10-09 GB GB868624213A patent/GB8624213D0/en active Pending
-
1987
- 1987-09-25 NL NL8702294A patent/NL8702294A/nl not_active Application Discontinuation
- 1987-09-25 HU HU874311A patent/HU201875B/hu not_active IP Right Cessation
- 1987-10-02 FR FR878713759A patent/FR2604902B1/fr not_active Expired - Lifetime
- 1987-10-02 CH CH3838/87A patent/CH675831A5/de not_active IP Right Cessation
- 1987-10-02 BE BE8701131A patent/BE1000732A5/fr not_active IP Right Cessation
- 1987-10-03 DE DE19873733540 patent/DE3733540A1/de not_active Withdrawn
- 1987-10-06 LU LU87009A patent/LU87009A1/fr unknown
- 1987-10-06 IL IL84104A patent/IL84104A0/xx unknown
- 1987-10-06 KR KR870011168A patent/KR880004801A/ko not_active Application Discontinuation
- 1987-10-07 FI FI874414A patent/FI874414A/fi not_active IP Right Cessation
- 1987-10-07 GR GR871550A patent/GR871550B/el unknown
- 1987-10-07 GB GB8723515A patent/GB2195893B/en not_active Expired - Lifetime
- 1987-10-07 PT PT85880A patent/PT85880B/pt not_active IP Right Cessation
- 1987-10-07 AU AU79420/87A patent/AU7942087A/en not_active Abandoned
- 1987-10-07 NO NO874200A patent/NO874200L/no unknown
- 1987-10-07 NZ NZ222083A patent/NZ222083A/en unknown
- 1987-10-08 IT IT48469/87A patent/IT1221493B/it active
- 1987-10-08 SE SE8703889A patent/SE8703889L/ not_active Application Discontinuation
- 1987-10-08 PH PH35906A patent/PH24227A/en unknown
- 1987-10-08 JP JP62256149A patent/JPS63101334A/ja active Pending
- 1987-10-08 DK DK527487A patent/DK527487A/da not_active Application Discontinuation
- 1987-10-08 ES ES8702873A patent/ES2014518A6/es not_active Expired - Lifetime
- 1987-10-08 CA CA000548872A patent/CA1332809C/fr not_active Expired - Lifetime
- 1987-10-09 ZA ZA877617A patent/ZA877617B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU201875B (en) | 1991-01-28 |
| GB8624213D0 (en) | 1986-11-12 |
| GB8723515D0 (en) | 1987-11-11 |
| LU87009A1 (fr) | 1988-05-03 |
| GR871550B (en) | 1988-02-15 |
| PT85880B (pt) | 1990-07-31 |
| CH675831A5 (fr) | 1990-11-15 |
| GB2195893A (en) | 1988-04-20 |
| PT85880A (en) | 1987-11-01 |
| DK527487A (da) | 1988-04-10 |
| CA1332809C (fr) | 1994-11-01 |
| NZ222083A (en) | 1991-05-28 |
| SE8703889L (sv) | 1988-04-10 |
| BE1000732A5 (fr) | 1989-03-21 |
| FI874414A (fi) | 1988-04-10 |
| IT1221493B (it) | 1990-07-06 |
| ZA877617B (en) | 1989-05-30 |
| HUT52958A (en) | 1990-09-28 |
| FR2604902A1 (fr) | 1988-04-15 |
| KR880004801A (ko) | 1988-06-27 |
| IL84104A0 (en) | 1988-03-31 |
| NO874200L (no) | 1988-04-11 |
| PH24227A (en) | 1990-05-04 |
| NO874200D0 (no) | 1987-10-07 |
| DK527487D0 (da) | 1987-10-08 |
| ES2014518A6 (es) | 1990-07-16 |
| GB2195893B (en) | 1991-05-08 |
| JPS63101334A (ja) | 1988-05-06 |
| DE3733540A1 (de) | 1988-04-14 |
| IT8748469A0 (it) | 1987-10-08 |
| FI874414A0 (fi) | 1987-10-07 |
| SE8703889D0 (sv) | 1987-10-08 |
| AU7942087A (en) | 1988-04-14 |
| NL8702294A (nl) | 1988-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2624732B1 (fr) | Formulation pharmaceutique a liberation prolongee | |
| FR2636532B1 (fr) | Compositions pharmaceutiques | |
| FR2514642B1 (fr) | Compositions pharmaceutiques a liberation retardee | |
| DK481989A (da) | Farmaceutiske formuleringer | |
| GB2230185B (en) | Sustained release pharmaceutical compositions | |
| DK100488D0 (da) | Farmaceutisk plaster | |
| DE122004000023I2 (de) | Pharmazeutische Zusammensetzung | |
| FR2618673B1 (fr) | Formule medicamenteuse a liberation controlee | |
| IT8603467A0 (it) | Farmaci ad attivita'antiflogistica nuove formulazioni galeniche a cessione programmata contenenti | |
| NO884408L (no) | Kontrollerte frigjoeringsformuleringer av tetracyklinforbindelser. | |
| SE8801813D0 (sv) | Pharmaceutical composition | |
| MA26576A1 (fr) | Formulation pharmaceutique orale a liberation prolongee | |
| BE886973A (fr) | Compositions pharmaceutiques a liberation controlee de potassium | |
| NO176805C (no) | Slippmiddelblanding | |
| FR2600253B1 (fr) | Nouvelles compositions pharmaceutiques a base de ketotifene | |
| FR2604902B1 (fr) | Compositions pharmaceutiques a liberation prolongee | |
| MC1878A1 (fr) | Compositions pharmaceutiques | |
| ZA904925B (en) | Sustained release pharmaceutical compositions | |
| MX11584A (es) | Composiciones farmaceuticas | |
| FR2618676B1 (fr) | Compositions pharmaceutiques antivirales | |
| GB8624214D0 (en) | Sustained release pharmaceutical compositions | |
| DK638889A (da) | Farmaceutisk kombinationspraeparat | |
| LV5728A4 (lv) | Farmaceitiskas kompozicijas | |
| LV5734A4 (lv) | Farmaceitiskas kompozicijas | |
| DK533989D0 (da) | Oral doseringsform |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |